Table 2.
Peptide Sequences. Neopeptide sequences are underlined.
| gene | repeat | mutation frequency |
peptide length |
peptide sequence |
|---|---|---|---|---|
| AIM2(-1) | A(10) | 51.6% | 20 | VIKAKKKHREVKRTNSSQLV |
| TGFBR2(-1) | A(10) | 74.8% | 49 | LEDAASPKCIMKEKKSLVRLSSCVPVALMSAMTTSSSQKNITPAILTCC |
| TGFBR2(-1)-N | A(10) | 74.8% | 27 | LEDAASPKCIMKEKKSLVRLSSCVPVA |
| TGFBR2(-1)-C | A(10) | 74.8% | 31 | RLSSCVPVALMSAMTTSSSQKNITPAILTCC |
| CASP5(-1) | A(10) | 44.7% | 25 | QLRCWNTWAKMFFMVFLIIWQNTMF |
| TAF1B(-1) | A(11) | 74.6% | 40 | PNTQIKALNRGLKKKTILKKAGIGMCVKVSSIFFINKQKP |
| ZNF294(-1) | A(11) | 60.0% | 41 | SSLKSSKKKMVRLDLLMRYLKAIKRMKNVYLQKERRLKAGN |
| MARCKS(-1) | A(11) | 72.7% | 23 | TPSPSNETPKKKRSAFPSRSLSS |
| control peptide p16INK4a_76–105 | - | - | 30 | ATLTRPVHDAAREGFLDTLVVLHRAGARLD |